Caitong International Asset Management Co., LTD Crispr Therapeutics Ag Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 2,475 shares of CRSP stock, worth $129,244. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,475
Previous 2,475
-0.0%
Holding current value
$129,244
Previous $97.4 Million
-0.0%
% of portfolio
0.1%
Previous 0.1%
Shares
1 transactions
Others Institutions Holding CRSP
# of Institutions
483Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$469 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$457 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$199 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$145 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.75MShares$143 Million0.07% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.07B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....